En savoir plus

Dr Frédéric Bost

Inserm U1065 Bâtiment Archimed
151, route de St Antoine de Ginestière BP 2 3194
06204 Nice cedex 3

Approche spécifique de la thématique

Modifications métaboliques et hormonales associées à la formation des métastases prostatiques.

Etude de l'effet des perturbateurs endocriniens sur le métabolisme et l'agressivité des cellules cancéreuses de prostate.

Publications récentes dans la thématique Nutrition et Cancer

Dans des journaux scientifiques internationaux

• Kaminski L, Torrino S, Haider R, Roustan FR, Jaune E, Laurent K, Nottet N, Michiels JF, Gesson M, Rocchi S, Mazure NM, Durand M et al. PGC-1α inhibits polyamine synthesis to suppress prostate cancer aggressiveness. Cancer Research. 2019 Jul 1;79(13):3268-80. [Résumé PubMed PMID 31064849]

• Torrino S, Roustan FR, Kaminski L, Bertero T, Pisano S, Ambrosetti D, Dufies M, Uhler J.P, Lemichez E, Mettouchi A, Gesson M, Gaggioli C et al. UBTD1 is a mechano-regulator controlling cancer aggressiveness. EMBO Rep. 2019 Apr;20(4). pii: e46570. [Résumé PubMed PMID 30804013]

• Bost F, Kaminski L. The metabolic modulator PGC-1α in cancer. Am J of Cancer Res. 2019 Feb 1;9(2):198-211. [Résumé PubMed PMID 30906622]

• Meyenberg Cunha-de Padua M, Noleto GR, de Oliveira Petkowicz CL, Cadena SMSC, Bost F, Pouysségur J, Mazure NM. Hypoxia protects against the cell death triggered by oxovanadium-galactomannan complexes in HepG2 cells. Cell Mol Biol Lett. 2019 Mar 22;24:18. [Résumé PubMed PMID 30949212]

• Fabbri L, Bost F, Mazure NM. Primari cilia in cancer hallmarks. Int J Mol Sci. 2019 Mar 16;20(6). pii: E1336. [Résumé PubMed PMID 30884815]

• Fénichel P, Chevalier N. Is testicular germ cell cancer (TGCC) estrogen dependent? The role of endocrine disrupting chemicals (EDCs).Endocrinology. 2019 Oct 16. pii: en.2019-00486. [Epub ahead of print] [Résumé PubMed PMID 31617897]

• Fénichel P, Chevalier N, Lahlou N, Coquillard P, Wagner-Mahler K, Pugeat M, Panaïa-Ferrari P, Brucker-Davis F. Endocrine dsrupting chemicals interfere with leydig cell hormone pathways during testicular descent in idiopathic cryptorchidism. Front Endocrinol (Lausanne). 2019 Jan 10;9:786. [Résumé PubMed PMID 30687232]

• Haider R, Massa F, Kaminski L, Clavel S, Djabari Z, Robert G, Laurent K, Michiels JF, Durand M, Ricci JE, Tanti JF, Bost F et al. Sirtuin 7: a new marker of aggressiveness in prostate cancer. Oncotarget. 2017 Aug 24;8(44):77309-16. [Résumé PubMed PMID 29100388]

• Loubiere C, Clavel S, Gileeron J, Harriseh H, Fauconnier J, Ben-Sahra I, Kaminski L, Laurent K, Herkenne S, Lacas-Gervais S et al.  The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells Scientific Reports. 2017; Jul 11;7(1):5040.0. [Résumé PubMed PMID 28698627]

• Fenichel P, Rougier C, Hieronimus S, Chevalier N. Which origin for polycystic ovaries syndrome: Genetic, environmental or both? Ann Endocrinol (Paris). 2017 Jul;78(3):176-15. Epub 2017 Jun 9. Review. [Résumé PubMed PMID 28606381]

• Bost F, Decoux-Poullot AG, Tanti JF, Clavel S. Energy disruptors: rising stars in anticancer therapy? Oncogenesis. 2016 Jan 18;5:e188. [Résumé PubMed PMID 26779810]

• Chevalier N, Paul-Bellon R, Fénichel P. Comment on "Effects of atrazine on estrogen receptor α- and g protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts". Environ Health Perspect. 2016 Apr;124(4):A64-5. [Résumé PubMed PMID 27035794]